Osteopontin (OP), purified from rat bone, binds Ca2+ but whether diffe
rent molecular forms of OPs derived from non-osteogenic sources and no
n-phosphorylated OP also possess this property remains to be determine
d. Furthermore, it is not known which specific site or sites of the mo
lecule bind Ca2+. In the present study, following an established proce
dure, total proteins in the conditioned media from OP-synthesizing cel
l cultures were separated by SDS-PAGE, transferred to Immobilon-P memb
ranes, and incubated with (CaCl2)-Ca-45, then Ca2+ ions bound to prote
in bands were analyzed by autoradiography. Purified OPs, and synthetic
oligopeptides representing specific domains of the OP molecule were a
dsorbed on the membrane and processed as described above. Our results
show that OPs synthesized by normal rat kidney cells, oncogenically tr
ansformed Rat-1 cells, OP purified from human milk, and non-phosphoryl
ated OP secreted by 1(alpha),25-dihydroxyvitamin D-3-treated mouse epi
dermal JB6 cells all bind detectable levels of Ca2+ with specificity.
We also show that a synthetic peptide representing the domain of OP wh
ich contains nine consecutive aspartic acid residues binds Ca2+ with s
pecificity. It is probable, therefore, that a Ca2+-binding site reside
s in this region of the OP molecule. We conclude that Ca2+-binding is
a general property of OP, irrespective of its molecular mass and origi
n, and the phosphate moieties of OP may not influence the conformation
or accessibility of the Ca2+ affinity sites of the molecule.